These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27503643)

  • 21. Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG.
    Hotter GS; Wards BJ; Mouat P; Besra GS; Gomes J; Singh M; Bassett S; Kawakami P; Wheeler PR; de Lisle GW; Collins DM
    J Bacteriol; 2005 Apr; 187(7):2267-77. PubMed ID: 15774869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
    Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
    Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    Kanvatirth P; Jeeves RE; Bacon J; Besra GS; Alderwick LJ
    PLoS One; 2019; 14(3):e0213713. PubMed ID: 30861059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals.
    Romero B; Aranaz A; Bezos J; Alvarez J; de Juan L; Tariq Javed M; Mateos A; Gómez-Mampaso E; Domínguez L
    Tuberculosis (Edinb); 2007 Nov; 87(6):565-71. PubMed ID: 17900988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A; Morcillo N; Loureiro J; Quse V; Davenport S
    Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity-Based Lipid Esterase Profiling of M. bovis BCG at Different Metabolic States Using Tetrahydrolipstatin (THL) as Bait.
    Ravindran MS; Wenk MR
    Methods Mol Biol; 2017; 1491():75-85. PubMed ID: 27778282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].
    de Kantor IN; Lesslie IW
    Medicina (B Aires); 1974; 34(3):244-8. PubMed ID: 4212693
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic ascorbate as a pro-drug for hydrogen peroxide release to kill mycobacteria.
    Pei Z; Wu K; Li Z; Li C; Zeng L; Li F; Pei N; Liu H; Zhang SL; Song YZ; Zhang X; Xu J; Fan XY; Wang J
    Biomed Pharmacother; 2019 Jan; 109():2119-2127. PubMed ID: 30551469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
    Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
    Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dielectrophoretic characterization of antibiotic-treated Mycobacterium tuberculosis complex cells.
    Inoue S; Lee HB; Becker AL; Weigel KM; Kim JH; Lee KH; Cangelosi GA; Chung JH
    Anal Bioanal Chem; 2015 Oct; 407(25):7673-80. PubMed ID: 26231690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying and Tackling Emergent Vulnerability in Drug-Resistant Mycobacteria.
    Padiadpu J; Baloni P; Anand K; Munshi M; Thakur C; Mohan A; Singh A; Chandra N
    ACS Infect Dis; 2016 Sep; 2(9):592-607. PubMed ID: 27759382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.